Bracebridge Capital, LLC Q3 2023 significant ownership

Add to watchlist

Bracebridge Capital, LLC is required to file a 13D/G report to the SEC when the ownership of a company's total stock issue exceeds 5%.

Bracebridge Capital, LLC Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Quotient LtdFebruary 22, 202362,0300.3%
Clarus Therapeutics Holdings, Inc.July 06, 20221,461,8222.8%
PERNIX THERAPEUTICS HOLDINGS, INC.Sold outMay 26, 201600.0%

Compare quarters

Export Bracebridge Capital, LLC's holdings

CSVXLS